The cannabis sector is projected to experience a compound annual growth rate of 34% up until 2030, offering potential profit-making opportunities for investors. The legal landscape of cannabis and its constituents is rapidly changing, with numerous states and countries either decriminalizing or legalizing it. Particularly in the U.S., with the Drug Enforcement Administration (DEA) considering a shift in marijuana’s classification from a Schedule 1 to a Schedule 3 controlled substance, there are promising prospects for budding entrepreneurs and established businesses alike.
However, like any emerging sector, the cannabis industry is not without investment risks. It is essential for both novice and experienced investors to gain a comprehensive understanding of the modus operandi of this industry. The following text provides a swift overview of this burgeoning market, including a selection of leading cannabis stocks.
Green Thumb Industries is among the most prominent cannabis corporations in the U.S. It operates an expansive network encompassing over 100 retail cannabis outlets and 20 production facilities spread across 14 states. The company has consistently made profits annually since 2020, noting steady revenue growth and maintains a robust financial standing, even amidst unforeseen adversities in the broader economy and the cannabis sector. The anticipated expansion of the U.S. cannabis market bodes well for Green Thumb’s long-term growth aspirations.
Trulieve Cannabis holds the title of being the largest retailer of cannabis in the U.S., commanding a presence in eight states with 225 retail cannabis stores and 15 processing facilities stationed within six states. Similar to Green Thumb, Trulieve currently trades on the Over-the-Counter (OTC) markets within the U.S. National cannabis establishments face difficulties in securing capital from banks or financial entities due to the federal prohibition of marijuana.
Offering a solution to the capital crunch for burgeoning cannabis firms is Innovative Industrial Properties (IIP). The company purchases properties owned by U.S. medical cannabis operators and leases them back, providing the cannabis operators with immediate access to much-needed liquidity. Additionally, the lease agreements generate a consistent revenue stream for IIP.
In a rundown of cannabis stocks, one might not expect to find Quest Diagnostics. Yet, this global leader in laboratory testing services has found a unique niche in the expanding cannabis market. The surge in state-level legalization of marijuana has escalated the need for workplace drug testing. Quest provides these drug testing services and is validated by the U.S. Department of Health and Human Services to conduct federally mandated drug examinations for workers in certain safety-sensitive occupations.
Quest Diagnostics thus presents a compelling case for investors wanting to capitalize on the growing acceptance of cannabis, while avoiding the industry’s intrinsic risks. The company is historically successful and consistently delivers profits.
On the other hand, Turning Point Brands has established itself as a preeminent supplier of smoking peripherals and oral tobacco. One can group the marijuana industry into three primary segments: Marijuana growers and retailers, those who cultivate, package, and sell cannabis products to end-users. Biotechnology firms that devise and market pharmaceuticals based on cannabis, and ancillary businesses that supply products and services to cannabis companies without handling the plant directly.
Cannabis usage is either medical or recreational. Medical patients utilize cannabis or its derivatives to alleviate health conditions under medical supervision, while recreational users, aged 18 and over, procure marijuana or its extracts for pleasure, provided they live in a region where recreational use is legally permitted.
Geographical location plays a role in cannabis legalities. Many more countries sanction medical cannabis compared to recreational cannabis. In the U.S., the federal prohibition of cannabis persists, but an increasing number of states have approved either medical or recreational cannabis use.
The swift-paced expansion of the U.S. cannabis market is driving substantial growth for U.S.-based cannabis companies. In contrast, Canadian marijuana companies, notwithstanding nationwide legalization, are experiencing slower expansion. It’s important to note that stocks related to the marijuana industry can exhibit high volatility. This feature discourages margin buying and should be avoided.
The cannabis industry is still in its infancy with significant market opportunities, particularly as more U.S. states accept cannabis. Investments in this sector are risky but have high-reward potential. Companies like Innovative Industrial Properties, a real estate trust focused on cannabis, boast the most significant market cap in this industry. Nonetheless, other entities with indirect industry links, such as Quest Diagnostics, are even larger.
By estimates, global revenue for the cannabis industry may reach approximately $68.5 billion by 2025, per data from Statista. This figure includes revenue from medical and recreational cannabis, along with products infused with cannabidiol (CBD).
Your investment decisions concerning cannabis stocks should align your risk appetite. For conservative investors, less risky alternatives may be preferable. However, for the risk-tolerant investor, the cannabis industry holds promising long-term prospects.
The post Explosive Growth Projected for Cannabis Sector till 2030 appeared first on Real News Now.
About Author
